{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:30:23Z","timestamp":1793997023182,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI16456"],"award-info":[{"award-number":["UM1AI16456"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-treatment HIV controllers (PTC) offer a unique opportunity to uncover the determinants of durable remission after antiretroviral therapy (ART) interruption. Here, using six PTC and six post-treatment non-controllers from the pVISCONTI study in cynomolgus macaques, we identify associations between Natural Killer (NK) cell subsets and outcomes following ART interruption. NKG2Ahigh NK cells lacking NKp30\/NKp46 (NKG2AhighNKp30-NKp46-), shaped by the MHC backgrounds of the animals, were linked to improved post-treatment control; this NK subset displayed tissue-homing potential and preserved functionality despite infection, characterized by cytokine production and degranulation. Conversely, NKG2AlowNKp30\u2009+\u2009NKp46+ NK cells exhibited reduced cytotoxic potential and elevated IL-10\/IL-17A production, and their pre-infection levels were associated with higher viremia and larger viral reservoirs after ART interruption. Our study suggests that constitutive NK cell features, preserved by early ART initiation, may provide a favorable immune environment for post-treatment control. Our findings identify the NKG2A axis as a potential target to improve outcomes after ART interruption<\/jats:p>","DOI":"10.1038\/s41467-026-76699-7","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T12:35:25Z","timestamp":1787402125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Constitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study"],"prefix":"10.1038","volume":"17","author":[{"given":"Ana\u00efs","family":"Chapel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-4882","authenticated-orcid":false,"given":"Luis","family":"Romero-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-2521","authenticated-orcid":false,"given":"Caroline","family":"Passaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8599-2146","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Monceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevenn","family":"Volant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-3914","authenticated-orcid":false,"given":"Delphine","family":"Desjardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-0201","authenticated-orcid":false,"given":"Adeline","family":"Melard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-6313","authenticated-orcid":false,"given":"Nathalie","family":"Dereuddre-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-2990","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3854-2396","authenticated-orcid":false,"given":"Michaela","family":"M\u00fcller-Trutwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4928-4484","authenticated-orcid":false,"given":"Roger","family":"Le Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-7536","authenticated-orcid":false,"given":"Asier","family":"S\u00e1ez-Ciri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"76699_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/QAI.0000000000001220","volume":"74","author":"S Fidler","year":"2017","unstructured":"Fidler, S. et al. Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection. J. Acquir. Immune Defic. Syndr. 74, 126\u2013133 (2017).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"76699_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Post-Treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).","journal-title":"PLoS Pathog."},{"key":"76699_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/jac\/dkv084","volume":"70","author":"A Ch\u00e9ret","year":"2015","unstructured":"Ch\u00e9ret, A. et al. Combined ART started during acute HIV infection protects central memory CD41 T cells and can induce remission. J. Antimicrob. Chemother. 70, 2108\u20132120 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"76699_CR4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jac\/dks533","volume":"68","author":"L Hocqueloux","year":"2013","unstructured":"Hocqueloux, L. et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J. Antimicrob. Chemother. 68, 1169\u20131178 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"76699_CR5","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/infdis\/jiy479","volume":"218","author":"G Namazi","year":"2018","unstructured":"Namazi, G. et al. The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies. J. Infect. Dis. 218, 1954\u20131963 (2018).","journal-title":"J. Infect. Dis."},{"key":"76699_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56116-1","volume":"16","author":"JD Gunst","year":"2025","unstructured":"Gunst, J. D. et al. Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies. Nat. Commun. 16, 906 (2025).","journal-title":"Nat. Commun."},{"key":"76699_CR7","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/S2666-5247(21)00010-0","volume":"2","author":"M Massanella","year":"2021","unstructured":"Massanella, M. et al. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. Lancet Microbe 2, e198\u2013e209 (2021).","journal-title":"Lancet Microbe"},{"key":"76699_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004543","volume":"10","author":"A Schuetz","year":"2014","unstructured":"Schuetz, A. et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog. 10, e1004543 (2014).","journal-title":"PLoS Pathog."},{"key":"76699_CR9","doi-asserted-by":"publisher","first-page":"104253","DOI":"10.1016\/j.ebiom.2022.104253","volume":"84","author":"H Takata","year":"2022","unstructured":"Takata, H. et al. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+T cells. EBioMedicine 84, 104253 (2022).","journal-title":"EBioMedicine"},{"key":"76699_CR10","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/QAD.0000000000000734","volume":"29","author":"L Assoumou","year":"2015","unstructured":"Assoumou, L. et al. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control. AIDS 29, 2003\u20132007 (2015).","journal-title":"AIDS"},{"key":"76699_CR11","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1172\/JCI120549","volume":"128","author":"R Sharaf","year":"2018","unstructured":"Sharaf, R. et al. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J. Clin. Investig. 128, 4074\u20134085 (2018).","journal-title":"J. Clin. Investig."},{"key":"76699_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03267-22","volume":"11","author":"P Tr\u00e9meaux","year":"2023","unstructured":"Tr\u00e9meaux, P. et al. In-depth characterization of full-length archived viral genomes after nine years of posttreatment HIV control. Microbiol. Spectr. 11, e0326722 (2023).","journal-title":"Microbiol. Spectr."},{"key":"76699_CR13","volume":"6","author":"A Essat","year":"2025","unstructured":"Essat, A. et al. A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI\/PRIMO. Medecine 6, 100670 (2025).","journal-title":"Medecine"},{"key":"76699_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag1672","volume":"1","author":"A Horowitz","year":"2016","unstructured":"Horowitz, A. et al. Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci. Immunol. 1, eaag1672 (2016).","journal-title":"Sci. Immunol."},{"key":"76699_CR15","doi-asserted-by":"publisher","first-page":"e2218960120","DOI":"10.1073\/pnas.2218960120","volume":"120","author":"B Etemad","year":"2023","unstructured":"Etemad, B. et al. HIV post-treatment controllers have distinct immunological and virological features. Proc. Natl. Acad. Sci. USA 120, e2218960120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76699_CR16","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2352-3018(22)00302-2","volume":"10","author":"N Climent","year":"2023","unstructured":"Climent, N. et al. Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Lancet HIV 10, e42\u2013e51 (2023).","journal-title":"Lancet HIV"},{"key":"76699_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00700-17","volume":"91","author":"V Madhavi","year":"2017","unstructured":"Madhavi, V. et al. HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV. J. Virol. 91, e00700-17 (2017).","journal-title":"J. Virol."},{"key":"76699_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275\u20131286 (2012).","journal-title":"N. Engl. J. Med."},{"key":"76699_CR19","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.4049\/jimmunol.161.11.6433","volume":"161","author":"TA Fehniger","year":"1998","unstructured":"Fehniger, T. A. et al. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.  J. Immunol. 161, 6433\u20136438 (1998).","journal-title":"J. Immunol."},{"key":"76699_CR20","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/eji.200636290","volume":"36","author":"B Morandi","year":"2006","unstructured":"Morandi, B., Bougras, G., Muller, W. A., Ferlazzo, G. & M\u00fcnz, C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-\u03b3 secretion. Eur. J. Immunol. 36, 2394\u20132400 (2006).","journal-title":"Eur. J. Immunol."},{"key":"76699_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20082387","volume":"206","author":"SH Lee","year":"2009","unstructured":"Lee, S. H., Kim, K. S., Fodil-Cornu, N., Vidal, S. M. & Biron, C. A. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 206, 2235\u20132251 (2009).","journal-title":"J. Exp. Med."},{"key":"76699_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj7970","volume":"9","author":"M Kilian","year":"2024","unstructured":"Kilian, M. et al. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance. Sci. Immunol. 9, eadj7970 (2024).","journal-title":"Sci. Immunol."},{"key":"76699_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s42003-022-03619-y","volume":"5","author":"P Rascle","year":"2022","unstructured":"Rascle, P. et al. NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections. Commun. Biol. 5, 674 (2022).","journal-title":"Commun. Biol."},{"key":"76699_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21402-1","volume":"12","author":"N Huot","year":"2021","unstructured":"Huot, N. et al. SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity. Nat. Commun. 12, 1282 (2021).","journal-title":"Nat. Commun."},{"key":"76699_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44389-3","volume":"15","author":"C Passaes","year":"2024","unstructured":"Passaes, C. et al. Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+T-cells. Nat. Commun. 15, 178 (2024).","journal-title":"Nat. Commun."},{"key":"76699_CR26","doi-asserted-by":"publisher","first-page":"1423689","DOI":"10.3389\/fimmu.2024.1423689","volume":"15","author":"FJ Mor\u00e1n-Plata","year":"2024","unstructured":"Mor\u00e1n-Plata, F. J. et al. A novel NKp80-based strategy for universal identification of normal, reactive and tumor\/clonal natural killer-cells in blood. Front. Immunol. 15, 1423689 (2024).","journal-title":"Front. Immunol."},{"key":"76699_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101298","volume":"23","author":"A Orrantia","year":"2020","unstructured":"Orrantia, A. et al. A NKp80-based identification strategy reveals that CD56neg NK cells are not completely dysfunctional in health and disease. iScience 23, 101298 (2020).","journal-title":"iScience"},{"key":"76699_CR28","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1182\/blood-2004-12-4762","volume":"106","author":"D Mavilio","year":"2005","unstructured":"Mavilio, D. et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 106, 1718\u20131725 (2005).","journal-title":"Blood"},{"key":"76699_CR29","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.0409872102","volume":"102","author":"D Mavilio","year":"2005","unstructured":"Mavilio, D. et al. Characterization of CD56\u2013\/CD16 + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102, 2886\u20132891 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76699_CR30","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.3390\/ijms20184490","volume":"20","author":"MG Desimio","year":"2019","unstructured":"Desimio, M. G., Covino, D. A. & Doria, M. Potential of the NKG2D\/NKG2DL axis in NK cell-mediated clearance of the HIV-1 reservoir. Int. J. Mol. Sci. 20, 4490 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"76699_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105948","volume":"120","author":"A Huber","year":"2025","unstructured":"Huber, A. et al. Phenotypic and epigenetic profiles of circulating NK cells in spontaneous HIV-1 controllers. EBioMedicine 120, 105948 (2025).","journal-title":"EBioMedicine"},{"key":"76699_CR32","doi-asserted-by":"crossref","unstructured":"Pohlmeyer, C. W. et al. Identification of NK cell subpopulations that differentiate HIV-infected subject cohorts with diverse levels of virus control. J. Virol. 93, e01790\u201318 (2019).","DOI":"10.1128\/JVI.01790-18"},{"key":"76699_CR33","doi-asserted-by":"crossref","unstructured":"Wang, X. & Zhao, X.-Y. Transcription factors associated with IL-15 cytokine signaling during NK cell development. Front. Immunol. 12, 610789 (2021).","DOI":"10.3389\/fimmu.2021.610789"},{"key":"76699_CR34","doi-asserted-by":"crossref","unstructured":"Peppa, D. et al. Adaptive reconfiguration of natural killer cells in HIV-1 infection. Front. Immunol. 9, 474 (2018).","DOI":"10.3389\/fimmu.2018.00474"},{"key":"76699_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00251-009-0369-8","volume":"61","author":"ET Mee","year":"2009","unstructured":"Mee, E. T. et al. MHC haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques. Immunogenetics 61, 327\u2013339 (2009).","journal-title":"Immunogenetics"},{"key":"76699_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1128\/JVI.01841-06","volume":"81","author":"RW Wiseman","year":"2007","unstructured":"Wiseman, R. W. et al. Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. J. Virol. 81, 349\u2013361 (2007).","journal-title":"J. Virol."},{"key":"76699_CR37","doi-asserted-by":"crossref","unstructured":"Zhang, Z. et al. Changes in NK cell subsets and receptor expressions in HIV-1 infected chronic patients and HIV controllers. Front. Immunol. 12, 792775 (2021).","DOI":"10.3389\/fimmu.2021.792775"},{"key":"76699_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69848-5","volume":"17","author":"S Hua","year":"2026","unstructured":"Hua, S. et al. Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques. Nat. Commun. 17, 3111 (2026).","journal-title":"Nat. Commun."},{"key":"76699_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fimmu.2015.00495","volume":"6","author":"U Hadad","year":"2015","unstructured":"Hadad, U. et al. NKp46 clusters at the immune synapse and regulates NK cell polarization. Front. Immunol. 6, 495 (2015).","journal-title":"Front. Immunol."},{"key":"76699_CR40","doi-asserted-by":"publisher","first-page":"e1274478","DOI":"10.1080\/2162402X.2016.1274478","volume":"6","author":"M Boieri","year":"2017","unstructured":"Boieri, M. et al. IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo. Oncoimmunology 6, e1274478 (2017).","journal-title":"Oncoimmunology"},{"key":"76699_CR41","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3389\/fimmu.2020.02134","volume":"11","author":"N Huot","year":"2020","unstructured":"Huot, N. et al. Non-human primate determinants of natural killer cells in tissues at steady-state and during simian immunodeficiency virus infection. Front. Immunol. 11, 2134 (2020).","journal-title":"Front. Immunol."},{"key":"76699_CR42","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/eji.200635901","volume":"36","author":"ML LaBonte","year":"2006","unstructured":"LaBonte, M. L., McKay, P. F. & Letvin, N. L. Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C\/C2 expression. Eur. J. Immunol. 36, 2424\u20132433 (2006).","journal-title":"Eur. J. Immunol."},{"key":"76699_CR43","doi-asserted-by":"publisher","first-page":"1027855","DOI":"10.3389\/fimmu.2022.1027855","volume":"13","author":"L Romero-Mart\u00edn","year":"2022","unstructured":"Romero-Mart\u00edn, L. et al. Disruption of the HLA-E\/NKG2X axis is associated with uncontrolled HIV infections. Front. Immunol. 13, 1027855 (2022).","journal-title":"Front. Immunol."},{"key":"76699_CR44","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","volume":"106","author":"G Alter","year":"2005","unstructured":"Alter, G. et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106, 3366\u20133369 (2005).","journal-title":"Blood"},{"key":"76699_CR45","doi-asserted-by":"publisher","first-page":"9909","DOI":"10.1128\/JVI.01546-15","volume":"89","author":"I Lisovsky","year":"2015","unstructured":"Lisovsky, I. et al. A higher frequency of NKG2A + than of NKG2A\u2212NK cells responds to autologous HIV-infected CD4 cells irrespective of whether or not they coexpress KIR3DL1. J. Virol. 89, 9909\u20139919 (2015).","journal-title":"J. Virol."},{"key":"76699_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/cei.12187","volume":"174","author":"AM Merino","year":"2013","unstructured":"Merino, A. M. et al. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin. Exp. Immunol. 174, 414\u2013423 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"76699_CR47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.182660","volume":"9","author":"N S\u00e1nchez-Gaona","year":"2024","unstructured":"S\u00e1nchez-Gaona, N. et al. NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control. JCI Insight 9, e182660 (2024).","journal-title":"JCI Insight"},{"key":"76699_CR48","doi-asserted-by":"publisher","first-page":"eadi3974","DOI":"10.1126\/sciimmunol.adi3974","volume":"8","author":"S Jost","year":"2023","unstructured":"Jost, S. et al. Antigen-specific memory NK cell responses against HIV and influenza use the NKG2\/HLA-E axis. Sci. Immunol. 8, eadi3974 (2023).","journal-title":"Sci. Immunol."},{"key":"76699_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005421","volume":"12","author":"ZB Davis","year":"2016","unstructured":"Davis, Z. B. et al. A conserved HIV-1-derived peptide presented by HLA-E renders infected T-cells highly susceptible to attack by NKG2A\/CD94-bearing natural killer cells. PLoS Pathog. 12, e1005421 (2016).","journal-title":"PLoS Pathog."},{"key":"76699_CR50","doi-asserted-by":"crossref","unstructured":"van Stigt Thans, T. et al. Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression. J. Virol. 93, e00719-19 (2019).","DOI":"10.1128\/JVI.00719-19"},{"key":"76699_CR51","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1083\/jcb.151.6.1281","volume":"151","author":"N Signoret","year":"2000","unstructured":"Signoret, N., Pelchen-Matthews, A., Mack, M., Proudfoot, A. E. I. & Marsh, M. Endocytosis and recycling of the HIV coreceptor Ccr5. J. Cell Biol. 151, 1281\u20131294 (2000).","journal-title":"J. Cell Biol."},{"key":"76699_CR52","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","volume":"270","author":"F Cocchi","year":"1995","unstructured":"Cocchi, F. et al. Identification of RANTES, MIP-1\u03b1, and MIP-1\u03b2 as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811\u20131815 (1995).","journal-title":"Science"},{"key":"76699_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56554","volume":"9","author":"JLG Ni\u00f1o","year":"2020","unstructured":"Ni\u00f1o, J. L. G. et al. Cytotoxic T cells swarm by homotypic chemokine signalling. eLife 9, e56554 (2020).","journal-title":"eLife"},{"key":"76699_CR54","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.0730640100","volume":"100","author":"R Castriconi","year":"2003","unstructured":"Castriconi, R. et al. Transforming growth factor \u03b21 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100, 4120\u20134125 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76699_CR55","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1172\/JCI40913","volume":"120","author":"G Alter","year":"2010","unstructured":"Alter, G. et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J. Clin. Investig. 120, 1905\u20131913 (2010).","journal-title":"J. Clin. Investig."},{"key":"76699_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155251","volume":"132","author":"J Harper","year":"2022","unstructured":"Harper, J. et al. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy. J. Clin. Investig. 132, e155251 (2022).","journal-title":"J. Clin. Investig."},{"key":"76699_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/viro.1997.9026","volume":"243","author":"O Neildez","year":"1998","unstructured":"Neildez, O. et al. Selective quasispecies transmission after systemic or mucosal exposure of macaques to simian immunodeficiency virus. Virology 243, 12\u201320 (1998).","journal-title":"Virology"},{"key":"76699_CR58","doi-asserted-by":"crossref","unstructured":"Hofmann-Lehmann, R. et al. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res. Hum. Retroviruses 16, 1247\u201357 (2000).","DOI":"10.1089\/08892220050117014"},{"key":"76699_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00251-010-0504-6","volume":"63","author":"A Aarnink","year":"2011","unstructured":"Aarnink, A. et al. Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque. Immunogenetics 63, 267\u2013274 (2011).","journal-title":"Immunogenetics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76699-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76699-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:47:01Z","timestamp":1790308021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76699-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76699"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76699-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8789706\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10059"}}